Cellectis (CLLS) Cash & Current Investments (2016 - 2023)
Historic Cash & Current Investments for Cellectis (CLLS) over the last 11 years, with Q3 2023 value amounting to $93.2 million.
- Cellectis' Cash & Current Investments fell 5496.7% to $93.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was $93.2 million, marking a year-over-year decrease of 5496.7%. This contributed to the annual value of $104.4 million for FY2022, which is N/A changed from last year.
- According to the latest figures from Q3 2023, Cellectis' Cash & Current Investments is $93.2 million, which was down 5496.7% from $94.3 million recorded in Q2 2023.
- In the past 5 years, Cellectis' Cash & Current Investments ranged from a high of $451.9 million in Q2 2019 and a low of $20.1 million during Q1 2022
- Moreover, its 5-year median value for Cash & Current Investments was $243.0 million (2021), whereas its average is $230.4 million.
- Its Cash & Current Investments has fluctuated over the past 5 years, first plummeted by 9475.39% in 2021, then skyrocketed by 33925.58% in 2023.
- Cellectis' Cash & Current Investments (Quarter) stood at $360.9 million in 2019, then dropped by 25.68% to $268.2 million in 2020, then fell by 9.95% to $241.5 million in 2021, then tumbled by 56.77% to $104.4 million in 2022, then dropped by 10.73% to $93.2 million in 2023.
- Its last three reported values are $93.2 million in Q3 2023, $94.3 million for Q2 2023, and $88.2 million during Q1 2023.